s6y
Company name or ticker
Search
Kailera Therapeutics, Inc.
3
Tregoning Kathleen: Initial statement of beneficial ownership of securities
Filed
Wednesday, July 8, 2026
Period
Jun 29, 2026
Accession number
0001193125-26-298547
Documents
3
3
EX-24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header